Standard InChI: InChI=1S/C18H24F3N3O2/c1-3-12(2)16(25)24-10-8-15(9-11-24)23-17(26)22-14-6-4-13(5-7-14)18(19,20)21/h4-7,12,15H,3,8-11H2,1-2H3,(H2,22,23,26)/t12-/m0/s1
1.Lee KS, Liu JY, Wagner KM, Pakhomova S, Dong H, Morisseau C, Fu SH, Yang J, Wang P, Ulu A, Mate CA, Nguyen LV, Hwang SH, Edin ML, Mara AA, Wulff H, Newcomer ME, Zeldin DC, Hammock BD.. (2014) Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy., 57 (16):[PMID:25079952][10.1021/jm500694p]
2. (2016) Acyl piperidine inhibitors of soluble epoxide hydrolase,
3.Lee KSS,Ng JC,Yang J,Hwang SH,Morisseau C,Wagner K,Hammock BD. (2020) Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain., 28 (22):[PMID:33007552][10.1016/j.bmc.2020.115735]